Clinical Study
Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy
Table 3
Clinical data of patients before and after one injection.
| | Before injection (baseline) | After one injection | Paired t-test ( value) | Correlation ( and values) |
| BCVA (LogMAR) | | | <0.0001 | , | Mean | 1.9 ± 0.66 | 1.3 ± 0.85 | Range | 3–0.8 | 2.5–0.05 |
| VER amplitude | | | 0.0154 | , | Mean | 5.9 ± 6 | 10.1 ± 8.4 | Range | 0–22 | 1.7–32 |
| VER latency | | | 0.0291 | , | Mean | 156 ± 60.77 | 124.5 ± 31.44 | Range | 84–280 | 85–202 |
|
|
BCVA LogMAR: best-corrected visual acuity in logarithm minimal angle of resolution; VER: visual evoked response.
|